Gastric cancer is an aggressive disease with increasing global incidence in recent years. Human epidermal growth receptor 2 (HER2) is overexpressed in approximately 10–20% of gastric cancers. The implementation of targeted therapy against HER2 as part of the standard of care treatment in metastatic disease has improved the prognosis of this subset of patients. However, gastric cancer still has high mortality rates and urgently requires new treatment strategies. The combination of immunotherapy with HER2-targeted therapies has shown synergistic effects in preclinical models, this being the rationale behind exploring this combination in clinical trials in locally advanced and metastatic settings. Additionally, the irruption of antibody–drug conjugates and other novel HER2-targeted agents has led to the development of numerous clinical trials showing promising results. This review presents the molecular mechanisms supporting the use of HER2-targeted drugs in combination with immunotherapy and provides an overview of the therapeutic scenario of HER2-positive disease. We focus on the role of immunotherapy but also summarize emerging therapies and combinations under clinical research that may change the standard treatment in HER-2 positive disease in the future.

More from our Archive

• DOI: 10.3390/ijms241310846 2023

  Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review

  Achille Aveta, Simone Cilio, Roberto Contieri, Gianluca Spena, Luigi Napolitano, Celeste Manfredi, Antonio Franco, Fabio Crocerossa, Clara Cerrato, Matteo Ferro, Francesco Del Giudice, Paolo Verze, Francesco Lasorsa, Andrea Salonia, Rajesh Nair, Jochen Walz, Giuseppe Lucarelli, Savio Domenico Pandolfo

• DOI: 10.3390/cryst13071088 2023

  Synthesis, X-ray Crystal Structure, and Computational Characterization of Tetraphenylborate, 3-(5H-Dibenzo[a,d] cyclohepten-5-ylidene)-N, N-Dimethyl-1-propanamine

  Ahmed H. Bakheit, Rashad Al-Salahi, Hazem A. Ghabbour, Essam A. Ali, Obaid S. AlRuqi, Gamal A. E. Mostafa

• DOI: 10.3390/cryst13071087 2023

  Facile Synthesis of Ni-Doped ZnO Nanostructures via Laser-Assisted Chemical Bath Synthesis with High and Durable Photocatalytic Activity

  Samer H. Zyoud, Vanga Ganesh, Che Azurahanim Che Abdullah, Ibrahim S. Yahia, Ahed H. Zyoud, Atef F. I. Abdelkader, Malek G. Daher, Mohamed Nasor, Moyad Shahwan, Heba Y. Zahran, Mahmoud S. Abd El-sadek, Elbadawy A. Kamoun, Saleh M. Altarifi, Mohamed Sh. Abdel-wahab

• DOI: 10.1039/d3dt01845h 2023

  Controlled synthesis of ACo₂O₄ (A = Fe, Cu, Zn, Ni) as an environmentally friendly electrocatalyst for urea electrolysis

  Ping Li, Yanhong Wang, Xiaoqiang Du, Xiaoshuang Zhang

• DOI: 10.3390/ijms241311156 2023

  Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review

  Paulina Małkowska, Marek Sawczuk

• DOI: 10.3390/ijms241310989 2023

  Molecular Biological Effects of Weak Low-Frequency Magnetic Fields: Frequency–Amplitude Efficiency Windows and Possible Mechanisms

  Viacheslav V. Krylov, Elena A. Osipova

• DOI: 10.1039/d3qi00968h 2023

  Tumor-targeted dual-action NSAID-platinum(<scp>iv</scp>) anticancer prodrugs

  Alexander Kastner, Theresa Mendrina, Florian Bachmann, Walter Berger, Bernhard K. Keppler, Petra Heffeter, Christian R. Kowol

• DOI: 10.1039/d3qi01037f 2023

  Remarkable enhancement of optical and electric properties by temperature-controlled solid-phase molecular motion

  Meng-Meng Lun, Chang-Yuan Su, Qiang-Qiang Jia, Zhi-Xu Zhang, Jie Li, Hai-Feng Lu, Yi Zhang, Da-Wei Fu

• DOI: 10.3390/ijms241411471 2023

  Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression

  Maria Kotsari, Vassiliki Dimopoulou, John Koskinas, Athanasios Armakolas

• DOI: 10.3390/ijms241411403 2023

  HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies

  Anna Pous, Lucía Notario, Cinta Hierro, Laura Layos, Cristina Bugés